TITLE:
      Risperidone for the Treatment of Cocaine Dependence - 7
SUMMARY:
      The purpose of this study is to evaluate clinical safety and pharmacological efficacy in the
      treatment of cocaine dependence, to evaluate impact of treatment on craving, and to
      correlate evidence of baseline neurotoxic damage of cocaine with treatment outcome and
      clinical side-effects.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the
        study and sign informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
        and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.
        Acute hepatitis. Other medical condtions that deem participation to be unsafe.
